-
-
-
-
-
-
-
Truist Securities Upgrades Tandem Diabetes Care (TNDM) to Buy
-
-
-
-
-
-
-
Tandem Diabetes Care (TNDM) PT Raised at Piper Sandler Following 'More Positive Results'
-
-
-
-
-
-
-
Citi Adds 90-Day Catalyst Watch on Tandem Diabetes Care (TNDM)
-
-
-
-
-
-
-
Oppenheimer Assumes Tandem Diabetes Care (TNDM) at Outperform
-
-
-
-
-
-
-
Tandem Diabetes (TNDM) Misses Q2 EPS by 38c, provides guidance
-
-
-
-
-
-
-
Tandem Diabetes Care (TNDM) PT Raised to $59 at Canaccord Genuity
-
-
-
-
-
-
-
Citi Downgrades Tandem Diabetes Care (TNDM) to Neutral
-
416,803 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

